SLC2A1 and neoplasm: In order to enhance tumor targeting as well as penetration, Lee and coworkers have developed a nanosystem based on amphiphilic hyaluronic acid-ceramide-dopamine conjugate to delivery GLUT1 inhibitor phloretin (Figure 2A) 74.